ScholarIQanswers from OpenAlex

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease

PaperCitations, authors & open-access status

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease have?

ScholarIQcitation count

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease has 5 citations in the OpenAlex counts ScholarIQ stores.

When was Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease published?

ScholarIQyear

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease has 2025 year in the ScholarIQ index.

What is the open-access status of Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease?

ScholarIQoa status

Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease has green oa status in the ScholarIQ index.

What is the DOI of Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease?

ScholarIQdoi

The DOI for Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease is on the source record.

What is the PMID of Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease?

ScholarIQpmid

The PMID for Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease is on the source record.

What is the OpenAlex record for Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease?

ScholarIQopenalex

The OpenAlex for Semaglutide and Hospitalizations in Patients With Obesity and Established Cardiovascular Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial